Atlas Trials

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

Clinical trial NCT02700048 · TERMINATED

Trial details

NCT number
NCT02700048
Sponsor
University of Minnesota
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hypoglycemia UnawarenessType 1 Diabetes
Start date
2016-06-01
Primary completion
2021-07-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.